HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- (3- picolinium)- 12- triethylammonium- dodecane dibromide

nicotinic receptor antagonist for the treatment of nicotine addiction; structure in first source

Also Known As:

TMPD cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Picolines: 14
      - 1-(3-picolinium)-12-triethylammonium-dodecane dibromide: 1

Experts

1.	Bardo, Michael T: 1 article (10/2007)
2.	Crooks, Peter A: 1 article (10/2007)
3.	Dwoskin, Linda P: 1 article (10/2007)
4.	Joyce, B Matthew: 1 article (10/2007)
5.	Lockman, Paul: 1 article (10/2007)
6.	Manda, Vamshi K: 1 article (10/2007)
7.	Neugebauer, Nichole M: 1 article (10/2007)
8.	Papke, Roger L: 1 article (10/2007)
9.	Zheng, Guangrong: 1 article (10/2007)

Related Diseases

1.	Tobacco Use Disorder (Nicotine Dependence) 10/15/2007 - "Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD)."

Related Drugs and Biologics

1.	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)